Dr. Stephen Field

Dr. Stephen Field

Position in Division

Clinical Respirologist, Asst Director, TB services

University Title

Clinical Professor

Clinical Interests

Research Interests

Training

Recent Publications

  1. Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O’Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie, R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Prins A, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M. Treatment of chronic obstructive pulmonary disease using combinations of tiotropium, salmeterol, and fluticasone: the Canadian optimal therapy of COPD trial. (submitted)
  2. Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006;129:1653-72
  3. Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, Illueca M, Beckman O, Sostek MB. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006;173:1091-9
  4. Huiming Y, Field S, Fisher D, Cowie R. Tuberculosis in Calgary, Canada, 1995-2002: site of disease and drug susceptibility. Int J Tuberc Lung Disease 2005;9:288-93
  5. Field SK. Corticosteroids and/or cytotoxic agents should be used early in the management of patients with idiopathic pulmonary fibrosis-the con argument. Can Respir J 2004;11:212-13
  6. Cowie RL, Underwood MF, Field SK. Inhaled corticosteroid therapy does not control asthma. Can Respir J 2004;11;555-8
  7. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients not infected with human immunodeficiency virus. Chest 2004;126:566-8
  8. Field SK, Cowie RL. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol and clofazimine. Chest 2003;124:1482-6
  9. Marrie TJ, Low DE, De Carolis E and the Canadian Community-Acquired Pneumonia Investigators-Duperval R, Field S, Louie T, Houston S, Gribble M, Williams K, Nicolle L, Grossman R, Salit I, Saginur R, Gregson D, Laverdiere M, Joly J, Hutchison J. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology- results from a Canadian multicentre study. Can Respir J 2003;10:368-74
  10. Marrie TJ, Peeling RW, Reid T, De Carolis E and the Canadian Community-Acquired Pneumonia Investigators- Duperval R, Field S, Louie T, Houston S, Gribble M, Williams K, Nicolle L, Grossman R, Salit I, Saginur R, Gregson D, Laverdiere M, Joly J, Hutchison J. Chlamydia species as a cause of community-acquied pneumonia in Canada. Eur Respir J 2003;21:779-84
  11. Field SK, Cowie RL. How to recognize and treat reflux in patients with asthma. J Respir Dis 2003;24:152-157
  12. Marrie TJ, De Carolis E, Yu VL, Stout J, and the Canadian community-acquired pneumonia investigators- Duperval R, Field S, Louie T, Houston S, Gribble M, Williams K, Nicolle L, Grossman R, Salit I, Saginur R, Gregson D, Laverdiere M, Joly J, Hutchison J. Legionnaire’s Disease-results of a multicentre Canadian Study. Can J Infect Dis 2003;14:154-8
Dr. Stephen Field's Hobby